Archives

by in
Entry Author Date Location
3 Life Sciences Companies That Are Built to Last 12/02/13 National
How Alkermes Survived a Brush With Death 11/11/13 National
Immunogen Halts Study as Cancer Drug Flops, Shares Fall 11/05/13 Boston
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More 10/25/13 Boston
DeCode Spinout, NextCode Health, Launches With $15M From Arch, Polaris 10/23/13 Boston
21 Red Flags to Watch for in a Biotech Company 10/21/13 National
Regeneron, Sanofi Pass First Key Test With Cholesterol-Lowering Drug 10/16/13 New York
The Human Genome Project Wasn’t Overhyped. The Payoff Just Took Time 10/03/13 National
Biotech CEOs Don’t Know It All. They Need Mentors 09/26/13 San Diego
The Best Biotech Graduate Schools in Real Life 09/23/13 National
Langer’s Bind Therapeutics Prices IPO at $15 Per Share 09/20/13 Boston
Disappointments, New Prospects for Rigel Pharmaceuticals 09/10/13 San Francisco
Are Some Degrees Better than Others for Big Pharma Leaders? 09/09/13 Seattle
East Coast Life Sciences Roundup: Syndax, Enteris, Invivo, & More 08/30/13 Boston
Amgen Agrees to Buy Onyx for $125 Per Share, or $10.4B 08/25/13 San Francisco
Hutch’s “Project Violet” Taps Crowd, Seeks $20M for Drug Discovery 08/15/13 Seattle
Buoyed by Partnerships, Bind Therapeutics Floats $80.5M IPO Plan 08/12/13 Boston
Array Biopharma Cuts Staff by 20%, Loses Development Deal with Amgen 08/07/13 Boulder/Denver
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
Why I Won’t Cheer If Onyx Pharma Is Sold for Megabucks 07/15/13 National
Baseball and Biopharma: More Alike Than You Might Realize 07/03/13 Seattle
NGM, Partners Seek Next Diabetes Drug Targets Among GI Tract Hormones 06/25/13 San Francisco
Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian 06/10/13 National
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies 06/06/13 San Francisco
We Owe it to Patients to Provide a Reliable Supply of Medicines 06/04/13 National
Assigning Credit and Blame to Biopharma R&D Chiefs 05/29/13 Seattle
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
Atlas Leans on Amgen, Novartis to Build New Startups 05/16/13 Boston
Radius Health CEO: Skin Patch Data is the Value Driver 05/13/13 Boston
Page 2 of 13 « previous page · next page »